Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $495,258 - $597,839
1,842 Added 1.68%
111,213 $31.6 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $150,351 - $169,614
588 Added 0.54%
109,371 $31.5 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $1.42 Million - $1.76 Million
6,482 Added 6.34%
108,783 $29.2 Million
Q2 2023

Aug 09, 2023

BUY
$214.27 - $253.37 $1.75 Million - $2.07 Million
8,182 Added 8.69%
102,301 $22.7 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $1.66 Million - $2.03 Million
7,371 Added 8.5%
94,119 $22.8 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $2.16 Million - $2.74 Million
9,432 Added 12.2%
86,748 $22.8 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $2.52 Million - $2.84 Million
11,222 Added 16.98%
77,316 $17.4 Million
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $1.47 Million - $1.63 Million
6,363 Added 10.65%
66,094 $16.1 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $483,928 - $535,351
2,207 Added 3.84%
59,731 $14.4 Million
Q4 2021

Feb 14, 2022

SELL
$198.88 - $227.6 $1.01 Million - $1.15 Million
-5,060 Reduced 8.09%
57,524 $12.9 Million
Q3 2021

Nov 16, 2021

BUY
$212.27 - $248.7 $608,365 - $712,774
2,866 Added 4.8%
62,584 $13.3 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $7.94 Million - $8.81 Million
34,011 Added 132.3%
59,718 $14.6 Million
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $231,452 - $269,719
-1,043 Reduced 3.9%
25,707 $6.4 Million
Q4 2020

Feb 17, 2021

SELL
$216.38 - $257.67 $115,546 - $137,595
-534 Reduced 1.96%
26,750 $6.15 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $182,088 - $202,497
776 Added 2.93%
27,284 $6.93 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $71,409 - $87,629
361 Added 1.38%
26,508 $6.25 Million
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $16,766 - $22,236
-92 Reduced 0.35%
26,147 $5.3 Million
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $182,020 - $233,958
962 Added 3.81%
26,239 $6.32 Million
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $44,223 - $52,989
-254 Reduced 0.99%
25,277 $4.91 Million
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $294,725 - $345,484
1,768 Added 7.44%
25,531 $4.71 Million
Q1 2019

May 06, 2019

BUY
$180.87 - $203.88 $432,641 - $487,680
2,392 Added 11.19%
23,763 $4.51 Million
Q4 2018

Feb 15, 2019

SELL
$178.4 - $208.25 $29,614 - $34,569
-166 Reduced 0.77%
21,371 $4.17 Million
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $371,321 - $418,615
2,004 Added 10.26%
21,537 $4.45 Million
Q2 2018

Aug 14, 2018

SELL
$166.05 - $186.51 $338,409 - $380,107
-2,038 Reduced 9.45%
19,533 $3.6 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $35,919 - $41,976
212 Added 0.99%
21,571 $3.67 Million
Q4 2017

Feb 08, 2018

SELL
$168.79 - $188.59 $8,439 - $9,429
-50 Reduced 0.23%
21,359 $3.72 Million
Q3 2017

Nov 16, 2017

BUY
$167.29 - $191.0 $74,611 - $85,186
446 Added 2.13%
21,409 $4 Million
Q2 2017

Aug 14, 2017

BUY
N/A
20,963
20,963 $3.61 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $174B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cetera Advisor Networks LLC Portfolio

Follow Cetera Advisor Networks LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.